Yuvraj

Alzheon to advance ALZ-801 into Phase II trial in patients with Alzheimer’s disease

Alzheon announced the launch of the company, the securing of initial private financing, and the signing of an exclusive license agreement to a novel...

InnoCore, Allergan to develop new drug delivery products for ophthalmic diseases

Netherland-based injectable drug delivery products producer InnoCore Pharmaceuticals has signed an exclusive license and collaboration agreement with Allergan (AGN), to develop new medicines for...

Banook Central Imaging selected by Servier to provide innovative image analysis services based on a combination of RECIST, IrRC and TGR criteria

Banook Central Imaging (Banook CI), a global imaging core lab for drug and device clinical trials, announces today that it has been selected by...

6th International Conference on Drug Discovery and Therapy

It is a great pleasure of Eureka Science to announce the latest editions of our very successful series of conferences; the “6th International Conference...

SMi present the 13th annual event – Advances and Progress in Drug Design

SPONSORED BY CHEMICAL COMPUTING GROUPSMi are proud to present the 13th annual Advances and Progress in Drug Design conference, convening in Central London on...

Agilent Technologies and Seoul National University Hospital Collaborate on Biomarker Research

Agilent Technologies Inc. and Seoul National University Hospital one of Korea’s top medical centers today announced a strategic collaboration for the development and verification...

Abbott reports third-quarter 2013 results

Abbott today announced financial results for the third quarter ended Sept. 30, 2013. Third-quarter 2013 worldwide sales of $5.4 billion increased 4.3 percent on...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read